|
| |
Scanner Operators and
Business Builders Wanted
Tel: 020
8500 4685
b.udall@ntlworld.com
|
|
Nu Skin is part of a family of companies owned
by Nu Skin Enterprises—-one of the largest direct-selling companies in
the world, with operations in more than thirty countries throughout
Asia, Europe, and the Americas. Nu Skin Enterprises offers three
distinct, specialized business opportunities selling consumer products
and services: Nu Skin markets premium quality face, body, and hair care
products; Pharmanex is a science-based developer and producer of
nutritional supplements; and Big Planet concentrates on the marketing
and distribution of technology-based products and services.
Nu Skin Enterprises' stock is traded publicly on the New York Stock
Exchange under the symbol “NUS.” |
 |
By registering as a Distributor you will receive the
following benefits:
 | Shop Online for Nu Skin, Pharmanex, Big Planet, and Nourish the
Children products |
| Receive exclusive Online discounts |
| Receive exclusive shipping discounts |
| Purchase products at wholesale prices |
| Receive exclusive Distributor discounts |
| The opportunity to grow and manage a successful business |
Pharmanex, a Nu Skin Enterprises' company, is a leader in the research and
development of phyto-pharmaceutical and nutritional products. The company is
headquartered in Provo, Utah under the leadership of Dr. Joseph Chang.
Pharmanex employees are highly committed to accomplishing the company's
mission: to help people achieve more healthy and productive lives.
In 1998, Pharmanex became a fully owned subsidiary of Nu Skin Enterprises
(NSE). NSE boasts more than a decade of innovation, financial stability and
leadership; and is now one of the largest direct-selling companies in the
world. The company generates annual global revenues of nearly $900 million
through its three divisions and holds approximately $600 million in assets.
It is publicly traded on the New York Stock Exchange (NYSE: NUS) and
currently operates in 34 countries around the world. Since partnering with
NSE, Pharmanex has been able to leverage its unique message and product
through a refined marketing system, offering unparalleled financial rewards
to its distributors, while simultaneously addressing the distinct needs of
the health-conscious consumer. With an aggressive global expansion plan in
place, Pharmanex will continue to propel to the forefront of the direct
selling industry. Already, Pharmanex annual world-wide sales have reached
nearly $400 million as its Distributor force has spread throughout the
United States, Asia and Europe.
A Story of Innovation, Commitment to Excellence and Determination to
Better People's Lives.
A leading pharmaceutical scientist, Dr. Michael Chang first conceived
Pharmanex in 1994. His vision was to create safe and efficient dietary
supplements by applying the disciplines of western science to natural
products.
During his 15 years in the pharmaceutical industry, Dr. Chang examined
50,000 different extracts, searching for ways to protect, preserve and
improve people's health. As Deputy Director of Medicinal Chemistry at
pharmaceutical giant Merck, Sharp and Dohme, he travelled the world looking
for "magic bullets," those single chemicals that could be taken from a
natural source and transformed into a drug.
Pharmaceutical companies require that new products generate at least 100
million U.S. dollars in the first year to justify the cost of development.
These factors were not viable reasons to Dr. Chang for discarding
potentially useful products. He realized the tremendous benefit of natural
products created, refined, and substantiated through a scientific
pharmaceutical approach-provided by nature, proven by science.
Dr. Chang eventually left the pharmaceutical industry to pursue his
vision of delivering natural nutraceutical products that could be
scientifically proven to change people's lives. His vision attracted the
business expertise needed to build a successful company. On October 18,
1998, Pharmanex was acquired by Nu Skin Enterprises, Inc. (NYSE: NUS), a
leading direct sales company.
With one of the premier distribution channels in the world, Pharmanex is
enjoying a major global expansion-creating an exciting opportunity to
further impact the masses in the global preventative healthcare markets.
There are many companies willing to let you sell their products and
provide business opportunities. Few of these companies will be around long
enough to support your business needs. You must find a company that provides
a real solution. This company must have a proven track record of integrity &
success, innovative and scientifically proven products, measurable and
guaranteed results, and patented technology.
Pharmanex is a division of Nu Skin Enterprises. Below are a few facts
about Pharmanex and Nu Skin Enterprises.
A proven track record of integrity & success
Nu Skin Enterprises has nearly 20 years of networking experience. We
received a 5A1 Dun & Bradstreet rating. We are traded on the New York Stock
Exchange under (NUS). Nu Skin Enterprises is proud to say we are a net debt
free company with $115 million in cash reserves. We also have $600 million
in infrastructure.
Innovative and scientifically proven products
We take pride in our products and have preformed scientific clinical studies
on our, Tegreen® 97, Cholestin®, LifePak®, and CordyMax® CS-4®.
Measurable and guaranteed results
We know that our LifePak® supplements are packed with antioxidants and will
help increase your antioxidant level. We are so sure that your antioxidant
level will increase that we have the LifePak® 60 day money back guarantee.
Patented Technology
Pharmanex holds several patents on its products some of these patents are
the Pharmanex Biophotonic Scanner and our 6s.
 |
| |
Pharmanex® uses proprietary technology in its manufacturing process to
maintain tight quality controls through all stages of product
development. The key to consistent quality is the Pharmanex 6S Quality
Process, the basis of the company's pharmaceutical approach to product
development. By applying this process, Pharmanex has consistently met or
exceeded the Good Manufacturing Practices (GMP) standards set by the FDA
for this product category. The 6S Quality Process has enabled Pharmanex
to become an industry leader in quality and efficacy.
Selection
To locate the botanicals with the most effective health-promoting
properties, Pharmanex employs teams of experts from the United States
and Asia. These teams conduct exhaustive research-compiling, reviewing,
and summarizing historical use and current intelligence about a
botanical's properties and health benefits. Pharmanex also conducts
original research to identify new botanicals, coordinating with noted
professionals at Purdue University, Kansas University, Columbia
University, Scripps Research Institute, and Beijing University, among
others. Only botanicals that pass extensive Pharmanex tests for
authenticity, usefulness, and safety are considered.
Sourcing
Once Pharmanex decides to proceed with a particular botanical, a team
investigates potential sources of the botanical and conducts exhaustive
analyses on samples from each source. Sources may be domestic or
international and may include Pharmanex cultivation areas in China and
Chile. Pharmanex chooses a supplier based on the quality and
concentration level of the active ingredient(s) present in samples from
that source.
Structure
Using state-of-the-art analytical techniques and working in
collaboration with respected universities and laboratories in both China
and the United States, Pharmanex conducts structural analyses of the
natural compounds present in the selected botanical. These analyses
isolate and purify specific chemical structures in standardized
extracts, a critical step in ensuring a safe and effective botanical.
Standardization
Wide variations in active ingredients are characteristic of any
botanical. For example, when Pharmanex analyzes potential Ginkgo biloba
leaves, studies reveal the concentrations of active components will vary
by as much as 300% depending on season, climate, soil, method of
harvest, storage conditions, and processing. Pharmanex optimizes the
active ingredients of a product through strict, proprietary
standardization processes (to at least one relevant marker molecule).
Each capsule of a Pharmanex product contains the same amount of each
active ingredient.
Safety
Pharmanex is leading the way in establishing strict standards to ensure
the safety of its products. Scientists research and document the history
of a product's use and safety. Pharmaceutical-grade tests for the
presence of microbes, toxins, and heavy metals are carried out for all
products. The active ingredient amount used is based on dosages found
effective through clinical trials and is backed by published data on
file at Pharmanex. Each product label details directions for use and
contains appropriate warning information.
Substantiation
Pharmanex only makes product claims that have been substantiated through
documented preclinical and clinical studies. Existing clinical data are
reviewed, and when necessary, Pharmanex sponsors studies of its
products. Data from some of these studies are subsequently submitted to
major international journals for review. This adherence to scientific
standards for substantiation helps make Pharmanex a leader in the
natural healthcare product industry. |
|
| Today, over 75 on staff scientists lead the
Pharmanex® research and development team. These scientists review published
clinical and scientific studies to identify botanicals that my have health
promoting properties. Original research is also coordinated with more than
150 noted scientists from around the world, representing such institutions
as Harvard, Stanford, UCLA, Columbia, Purdue, Beijing Medical University,
Shanghai Medical University and Peking University. Following are our Senior
Scientists. |
 |
Joseph Chang, Ph.D.
President of Pharmanex
Joseph Chang, Ph.D. serves as President of Pharmanex. Dr. Chang has
published numerous scientific papers, reviews, and books on pharmacological
research and has over 20 years experience in the healthcare industry. As an
established leader in bioscience, he has held various executive research
management positions with Wyeth-Ayerst, Rhone-Poulenc Rorer, and other
biotechnology companies involved in researching natural products for
arthritis and cancer treatment. He is a member of the American Society of
Pharmacology and Experimental Therapeutics, American Thoracic Society, and
New York Academy of Sciences. Dr. Chang holds a Ph.D. in pharmacology from
the University of London and was a postdoctoral fellow at the Johns Hopkins
University School of Public Health and Hygiene. |
|
|
Michael N. Chang, Ph.D.
Chief Scientific Advisor, Pharmanex Fellow
Michael N. Chang, Ph.D. is currently the Chief Scientific Advisor of Nu Skin
Enterprises, Inc. He is also the President and CEO of Optimer
Pharmaceutical, Inc. Before this he was the Founder and Senior Vice
President of Pharmanex. Prior to founding Pharmanex, Inc., Dr. Chang served
as Director of Medicinal Chemistry at Rhone Poulenc Rorer and Deputy
Director of Medicinal Chemistry at Merck. He has over 20 years of
pharmaceutical business experience and his previous management
responsibilities included the direction of numerous drug discovery projects
and several successful IND/NDA submissions. His research has resulted 35
patents and in more than 60 articles published in peer-reviewed journals.
Dr. Chang holds a Ph.D. in Organic Chemistry from Brandeis University and
completed his post-doctoral fellowship at MIT. |
 |
Carsten R. Smidt, Ph.D., FACN
Vice President of Global Research and Development
Dr. Carsten R. Smidt received his Doctorate in Nutrition Science and
Physiological Chemistry from the University of California at Davis, 1990.
Dr. Smidt has over 12 years of experience in the dietary supplement and
medical foods industry, including four years at the Mead Johnson Nutritional
Group, Bristol Myers-Squibb Company (developed Boost® energy drink).
Likewise, he has over seven years of experience as the leading research
scientist in new product development for Pharmanex. His professional areas
of interest include: Effects of nutrition and supplements on disease
prevention; Antioxidant nutrients. He developed the new LifePak and most of
the Pharmanex Solutions products. Dr. Smidt currently oversees all of the
Pharmanex research and development activities in Provo, Beijing and
Shanghai, including chemistry, information resources, scientific affairs,
clinical and pharmacological research.
| Member of American Society for Nutritional Sciences (ASNS), the
American Society of Clinical Nutrition (ASCN), and the German Society for
Nutrition (DGE). |
| Fellow of the American College of Nutrition (ACN).
|
|
<<Top
|
